[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69610036D1 - Pyridazinone-Derivate und Verfahren zur deren Herstellung - Google Patents

Pyridazinone-Derivate und Verfahren zur deren Herstellung

Info

Publication number
DE69610036D1
DE69610036D1 DE69610036T DE69610036T DE69610036D1 DE 69610036 D1 DE69610036 D1 DE 69610036D1 DE 69610036 T DE69610036 T DE 69610036T DE 69610036 T DE69610036 T DE 69610036T DE 69610036 D1 DE69610036 D1 DE 69610036D1
Authority
DE
Germany
Prior art keywords
preparation
pyridazinone derivatives
pyridazinone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69610036T
Other languages
English (en)
Other versions
DE69610036T2 (de
Inventor
Akihiko Ishida
Harutami Yamada
Michihisa Yato
Shinsuke Nishiyama
Fumikazu Okumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of DE69610036D1 publication Critical patent/DE69610036D1/de
Publication of DE69610036T2 publication Critical patent/DE69610036T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Couplings Of Light Guides (AREA)
DE69610036T 1995-06-27 1996-06-27 Pyridazinone-Derivate und Verfahren zur deren Herstellung Expired - Fee Related DE69610036T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16062095 1995-06-27
JP1985996 1996-02-06

Publications (2)

Publication Number Publication Date
DE69610036D1 true DE69610036D1 (de) 2000-10-05
DE69610036T2 DE69610036T2 (de) 2001-04-12

Family

ID=26356726

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69610036T Expired - Fee Related DE69610036T2 (de) 1995-06-27 1996-06-27 Pyridazinone-Derivate und Verfahren zur deren Herstellung

Country Status (21)

Country Link
US (2) US5698554A (de)
EP (1) EP0751132B1 (de)
KR (1) KR970061873A (de)
CN (1) CN1144802A (de)
AR (1) AR002602A1 (de)
AT (1) ATE195937T1 (de)
AU (1) AU694955B2 (de)
BG (1) BG62768B1 (de)
CA (1) CA2179939A1 (de)
DE (1) DE69610036T2 (de)
DK (1) DK0751132T3 (de)
ES (1) ES2151110T3 (de)
GR (1) GR3034910T3 (de)
HU (1) HUP9601766A3 (de)
IL (1) IL118631A (de)
MY (1) MY132263A (de)
NO (1) NO311084B1 (de)
PT (1) PT751132E (de)
RU (1) RU2131419C1 (de)
SG (1) SG46741A1 (de)
TW (1) TW432052B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2235911C (en) * 1997-05-27 2003-07-29 Schneider (Usa) Inc. Stent and stent-graft for treating branched vessels
KR20030061051A (ko) * 2002-01-07 2003-07-18 대한민국 (경상대학교 총장) 신규한 아렌(혹은 알케인)술폰일피리다진온 유도체, 이의제조방법 및 유기반응에서의 용도
AR050552A1 (es) * 2004-09-02 2006-11-01 Osi Pharm Inc Mercaptoamidas como inhibidores de histona desacetilasa
ZA200807796B (en) * 2006-03-17 2009-12-30 Sumitomo Chemical Co Pyridazinone compound and use thereof as herbicides
EA017004B1 (ru) * 2006-07-25 2012-09-28 Сефалон, Инк. Пиридизиноновые производные
EP2220073B1 (de) * 2007-11-15 2014-09-03 MSD Italia S.r.l. Pyridazinonderivate als parp-inhibitoren
US9062057B2 (en) 2010-03-19 2015-06-23 Purdue Research Foundation CCR5 antagonists for treating HIV
EP2635572B1 (de) 2010-11-05 2018-10-17 Senomyx, Inc. Verbindungen als trpm8-modulatoren
MX2013015058A (es) 2011-06-24 2014-01-20 Amgen Inc Antagonistas de melastatina 8 de potencial receptor transitorio y su uso en tratamientos.
JP2014527511A (ja) 2011-06-24 2014-10-16 アムジエン・インコーポレーテツド Ｔｒｐｍ８拮抗剤及び治療におけるそれらの使用
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
CN108473484B (zh) 2015-10-01 2021-06-29 弗门尼舍公司 可用作trpm8调节剂的化合物
MY190795A (en) 2016-04-15 2022-05-12 Abbvie Inc Bromodomain inhibitors
CA3116931A1 (en) * 2018-10-30 2020-05-07 Nuvation Bio Inc. Heterocyclic compounds as bet inhibitors
HUE063586T2 (hu) 2018-11-06 2024-01-28 Edgewise Therapeutics Inc Piridazinon-vegyületek és alkalmazásaik
CN114286818B (zh) 2019-07-02 2024-09-20 诺维逊生物股份有限公司 作为bet抑制剂的杂环化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6053022B2 (ja) 1977-04-07 1985-11-22 ウェルファイド株式会社 ピリダジノン誘導体
GB8323553D0 (en) * 1983-09-02 1983-10-05 Smith Kline French Lab Pharmaceutical compositions
JPS6193169A (ja) * 1984-10-12 1986-05-12 Sankyo Co Ltd ピリダジノン誘導体及びその製法
KR860007219A (ko) * 1985-03-12 1986-10-08 베쩰, 좀머 설포닐아미노에틸 화합물의 제조방법
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3508692A1 (de) 1985-03-12 1986-09-18 Dr. Karl Thomae Gmbh, 7950 Biberach 3-(4-(2-benzolsulfonylamino-aethyl)-benzoyl)propionsaeure, diese verbindung enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3623944A1 (de) 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JPS63145272A (ja) * 1986-12-09 1988-06-17 Morishita Seiyaku Kk ４，５−ジヒドロ−６−（４−置換フエニル）−３（２ｈ）−ピリダジノン誘導体
DE3728491A1 (de) * 1987-08-26 1989-03-09 Heumann Pharma Gmbh & Co Dihydropyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4134467A1 (de) * 1991-10-18 1993-04-22 Thomae Gmbh Dr K Heterobiarylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0589037B1 (de) * 1991-03-01 1996-05-29 Zeria Pharmaceutical Co., Ltd. Indan-derivate als thromboxan-antagonisten
CA2099743A1 (en) * 1992-07-02 1994-01-03 Akihiko Ishida Pyridazinone derivatives and processes for preparing the same
JP2616584B2 (ja) * 1992-07-02 1997-06-04 田辺製薬株式会社 ピリダジノン誘導体及びその製法
JP2757353B2 (ja) * 1993-12-28 1998-05-25 田辺製薬株式会社 インダン誘導体、その製法及びその合成中間体
CA2139088A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivatives, processes for preparing the same and synthetic intermediate of the same
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same

Also Published As

Publication number Publication date
ES2151110T3 (es) 2000-12-16
RU2131419C1 (ru) 1999-06-10
BG100684A (bg) 1997-03-31
NO311084B1 (no) 2001-10-08
ATE195937T1 (de) 2000-09-15
NO962643D0 (no) 1996-06-21
MY132263A (en) 2007-09-28
NO962643L (no) 1996-12-30
DE69610036T2 (de) 2001-04-12
DK0751132T3 (da) 2000-11-13
US5808065A (en) 1998-09-15
HUP9601766A3 (en) 1998-04-28
IL118631A0 (en) 1996-10-16
CN1144802A (zh) 1997-03-12
HUP9601766A2 (en) 1997-02-28
EP0751132B1 (de) 2000-08-30
US5698554A (en) 1997-12-16
TW432052B (en) 2001-05-01
IL118631A (en) 2002-05-23
AR002602A1 (es) 1998-03-25
AU694955B2 (en) 1998-08-06
AU5622196A (en) 1997-01-09
PT751132E (pt) 2000-12-29
GR3034910T3 (en) 2001-02-28
KR970061873A (ko) 1997-09-12
SG46741A1 (en) 1998-02-20
EP0751132A1 (de) 1997-01-02
HU9601766D0 (en) 1996-08-28
CA2179939A1 (en) 1996-12-28
BG62768B1 (bg) 2000-07-31

Similar Documents

Publication Publication Date Title
DE69530989D1 (de) Neue pyrimidinderivate und verfahren zu ihrer herstellung
DE69530312D1 (de) Stabiles lycopin konzentrat und verfahren zu seiner herstellung
DE69635445T2 (de) Alkalialuminiumhydroxycarbonatzusammensetzung und verfahren zur herstellung
DE69616516D1 (de) Wasserschutzzusammensetzungen und verfahren zu deren herstellung
DE69610036D1 (de) Pyridazinone-Derivate und Verfahren zur deren Herstellung
DE69631739D1 (de) Poröser Film und Verfahren zu seiner Herstellung
DE69703993D1 (de) Einbügelbarer Einlagestoff und Verfahren zu dessen Herstellung
DE69613323D1 (de) Gleitwerkstoff und Verfahren zu seiner Herstellung
DE69602860D1 (de) Schreibgerät und Verfahren zu seiner Herstellung
DE69619067D1 (de) Verfahren zur Herstellung von 3-Amino-2-oxo-1-Halogenpropan-Derivaten
DE69608359D1 (de) Hexaazaisowurtzitan-derivate und verfahren zu deren herstellung
DE69301771D1 (de) T-Butyl-R-(-)-4-cyano-3-hydroxybutyrat und Verfahren zu seiner Herstellung
DE59603916D1 (de) Verfahren zur Herstellung von Imidazo-Benzodiazepin-Derivaten
DE69625253D1 (de) Verfahren zur Herstellung von Imidazochinazolinon-Derivaten
DE69532142D1 (de) Rohrförmige Substanz und Verfahren zur seiner Herstellung
DE69721237D1 (de) Verfahren zur herstellung von alkylethern und deren mischungen
DE69635421T2 (de) Verfahren zur herstellung von 2-chlorthiazolderivaten
ATE249452T1 (de) Verfahren und zwischenprodukte zur herstellung substituierter chromanolderivate
DE59606485D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE59606489D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE59500393D1 (de) Verfahren zur Herstellung von Cyclopropylalkylketonen und 4,5-Dihydroalkylfuranen
ATE214373T1 (de) Verfahren und zwischenprodukte zur herstellung substituierter indazolderivate
DE59402216D1 (de) Fullerenderivate, Verfahren zur Herstellung und deren Verwendung
DE69621747D1 (de) Verfahren zur Herstellung von Benzylacetat und Benzylalkohol
DE59606657D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee